Claritus Pharmaceuticals Inc. (CLAZF)

[skitahoe]

If the volume figure I'm reading is correct, I just bought more shares than were previously purchased today, and increased my position by 50%. I believe with news the volume should easily go to ten to 100 or more times what we're seeing these days, and the share price could more than double on anything that's really positive.

Right now I'd be happy if I could use their pain medication, but with surgery planned I'm not permitted the med they're combining the cannabis with. It would probably be great post therapy, but I'll be taking whatever the Dr. prescribes.

If Kalytera's GVHD formulation proves effective for organ transplants, as well as the stem cell targets it's aimed at, if the company isn't bought out, it could grow to double or triple digit billion dollar market caps over time. Of course the key is an approval for any indication, then Doctor's will be able to try it off label in other applications.

Gary